Loading company…
RudaCure develops treatments for dry eye, macular degeneration, and chronic pain.
RudaCure develops treatments for dry eye syndrome, age-related macular degeneration, neuropathic pain, and cancer pain. Its programs include RCI001, RCI002, and RCI005, and it also provides animal model and drug evaluation services. Founded in 2018 by CEO Yong-ho Kim, the company is based in Incheon, South Korea, and raised an undisclosed Series A investment from Darae Strategy & Business in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in